NCT05068609View on ClinicalTrials.gov

A Study of Nivolumab in Participants With Squamous Cell Carcinoma of the Head & Neck (SCCHN) - Patient Reported Outcomes (PRO)

CompletedOBSERVATIONAL
Enrollment

509

Participants

Timeline

Start Date

August 13, 2020

Primary Completion Date

October 18, 2021

Study Completion Date

October 18, 2021

Conditions
Squamous Cell Carcinoma of the Head and Neck
Interventions
BIOLOGICAL

Nivolumab

Participants in this study are being treated with nivolumab for SCCHN

Trial Locations (1)

08054

Local Institution, Mount Laurel

Sponsors
All Listed Sponsors
lead

Bristol-Myers Squibb

INDUSTRY